Showing results (111-120 of 128) with videos related to
Sort By:
Pageof 13
Frontiers in Oncology|March 10, 2023
MEK inhibition causes BIM stabilization and increased sensitivity to BCL-2 family member inhibitors in RAS-MAPK-mutated neuroblastomaThomas F Eleveld, Lindy Vernooij, Linda Schild, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 26, 2015
Equivalence Ratio for Daunorubicin to Doxorubicin in Relation to Late Heart Failure in Survivors of Childhood CancerElizabeth A M Feijen, Wendy M Leisenring, Kayla L Stratton, et al.European Journal of Cancer (Oxford, England : 1990)|July 17, 2013
The development of a clinical screening instrument for tumour predisposition syndromes in childhood cancer patientsSaskia M J Hopman, Johannes H M Merks, Corianne A J M de Borgie, et al.European Journal of Nuclear Medicine and Molecular Imaging|October 1, 2014
MIBG scans in patients with stage 4 neuroblastoma reveal two metastatic patterns, one is associated with MYCN amplification and in MYCN-amplified tumours correlates with a better prognosisGitta Bleeker, Berthe L van Eck-Smit, Koos H Zwinderman, et al.International Journal of Radiation Oncology, Biology, Physics|June 22, 2016
Risk of Symptomatic Stroke After Radiation Therapy for Childhood Cancer: A Long-Term Follow-Up Cohort AnalysisIrma W E M van Dijk, Helena J H van der Pal, Rob M van Os, et al.International Journal of Radiation Oncology, Biology, Physics|September 8, 2012
Dose-effect relationships for adverse events after cranial radiation therapy in long-term childhood cancer survivorsIrma W E M van Dijk, Mathilde C Cardous-Ubbink, Helena J H van der Pal, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 14, 2018
Peripheral Stem Cell Apheresis is Feasible Post <sup>131</sup>Iodine-Metaiodobenzylguanidine-Therapy in High-Risk Neuroblastoma, but Results in Delayed Platelet ReconstitutionKathelijne C J M Kraal, Ilse Timmerman, Hannah M Kansen, et al.Nature Genetics|August 4, 2015
A coding variant in RARG confers susceptibility to anthracycline-induced cardiotoxicity in childhood cancerFolefac Aminkeng, Amit P Bhavsar, Henk Visscher, et al.JCO Precision Oncology|May 26, 2021
Mesenchymal Neuroblastoma Cells Are Undetected by Current mRNA Marker Panels: The Development of a Specific Neuroblastoma Mesenchymal Minimal Residual Disease PanelEsther M van Wezel, Lieke M J van Zogchel, Jalenka van Wijk, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 10, 2003
Development of a real-time polymerase chain reaction assay for prediction of the uptake of meta-[(131)I]iodobenzylguanidine by neuroblastoma tumorsSean Carlin, Rob J Mairs, Anthony G McCluskey, et al.Pageof 13